Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
500 participants
INTERVENTIONAL
2023-08-31
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Randomized Controlled Study of Digitalized Cognitive-behavioral Intervention for Childhood Anxiety
NCT03310489
Mindfulness and Acceptance-Based Treatments for Social Anxiety: Defusion App
NCT02265211
Clinical Investigation of Wysa
NCT05533190
Evaluating the Effects of a Self-help Mobile Phone Application on Worry and Overthinking in Young Adults Aged Between 16 and 24.
NCT04950257
Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health Centers
NCT01416805
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For the purpose of this study participants will be recruited through different online channels and will be randomly assigned to either the intervention or control group. Regardless of their assignment they will be completing weekly standardized assessments examining their symptoms of anxiety and depression, and examining any improvement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Intervention
Wysa for Worry
The Wysa for Worry cCBT program is a week-based cCBT programme consisting of specialised cognitive behavior therapy (CBT) interventions delivered through a conversational agent.
Each week of the programme focuses on a different CBT technique or intervention, which is explained in a short weekly video. Following each video, the technique or intervention is discussed and practiced with Wysa's AI chatbot.
Control arm
App-based Psychoeducation
The control will include the weekly delivery of active psychoeducational resources.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wysa for Worry
The Wysa for Worry cCBT program is a week-based cCBT programme consisting of specialised cognitive behavior therapy (CBT) interventions delivered through a conversational agent.
Each week of the programme focuses on a different CBT technique or intervention, which is explained in a short weekly video. Following each video, the technique or intervention is discussed and practiced with Wysa's AI chatbot.
App-based Psychoeducation
The control will include the weekly delivery of active psychoeducational resources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have mild to moderate symptoms of anxiety (scores: 5-15, according to GAD-7).
* Patients who are not already engaged in psychological therapy and not intending to start psychological therapy in the next eight weeks.
* Patients who haven't used any DMHI (Digital Mental Health Interventions) in the last 6 months.
* Patients without risk of suicidal ideation and behaviour.
* Patients who are capable of reading and understanding English and have provided written or verbal informed consent to participate.
* Patients who own and use a smartphone with functional audio.
Exclusion Criteria
* Patients with diagnosis of or receiving treatment for alcohol/substance use disorder.
* Patients who've had their psychiatric medication or dose changed in the last 1 month.
* Patients who suffer from severe anxiety
* Patients with diagnosis of or receiving treatment for an active state of psychosis.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wysa
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Wysa_RCT_01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.